Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different …
Context In the absence of an effective vaccine, serogroup B Neisseria meningitidis (MenB)
remains a major cause of invasive disease in early childhood in developed countries. …
remains a major cause of invasive disease in early childhood in developed countries. …
[HTML][HTML] Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy
CA Jeppesen, MD Snape, H Robinson, N Gossger… - Journal of infection, 2015 - Elsevier
Objectives Recent development of serogroup B meningococcal (MenB) vaccines highlights
the importance of pharyngeal carriage data, particularly in adolescents and young adults, to …
the importance of pharyngeal carriage data, particularly in adolescents and young adults, to …
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
…, P Saroey, TM John, H Robinson, S Kelly, N Gossger… - Cmaj, 2013 - Can Med Assoc
Background: The multicomponent serogroup B meningococcal (4CMenB) vaccine was recently
licensed for use in Europe. There are currently no data on the persistence of bactericidal …
licensed for use in Europe. There are currently no data on the persistence of bactericidal …
Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of …
…, H Robinson, S Kelly, N Gossger… - The pediatric …, 2013 - journals.lww.com
Background: In a previous study, 60 infants receiving an investigational serogroup B
meningococcal vaccine containing recombinant meningococcal proteins alone (rMenB) or …
meningococcal vaccine containing recombinant meningococcal proteins alone (rMenB) or …
Inching toward a serogroup B meningococcal vaccine for infants
AC Cohn, NE Messonnier - JAMA, 2012 - jamanetwork.com
… The results of the study by Gossger et al 6 demonstrate this serogroup B vaccine is immunogenic
in infants; however, there is still much to understand about effective implementation of …
in infants; however, there is still much to understand about effective implementation of …
Meningococcal B vaccination: real-world experience and future perspectives
P Kuhdari, A Stefanati, S Lupi, N Valente… - Pathogens and Global …, 2016 - Taylor & Francis
Invasive meningococcal disease (IMD) represents a severe risk for health. It can be considered
the most dangerous vaccine-preventable disease due to the high probability of related …
the most dangerous vaccine-preventable disease due to the high probability of related …
[HTML][HTML] 73rd Congress of the Italian Society of Pediatrics
F Albano - Italian Journal of Pediatrics, 2017 - Springer
The Italian Ombudsperson for Childhood and Adolescence was established by Law no. 112
of 12 July 2011, with a view to ensuring the full implementation and protection of the rights …
of 12 July 2011, with a view to ensuring the full implementation and protection of the rights …
[PDF][PDF] Fast and accurate dynamic estimation of field effectiveness for meningococcal vaccines Supplementary Information
L Argante, M Tizzoni, D Medini - 2016 - researchgate.net
The relative risk is a ratio of two risks: the risk that a certain event occurs in a group of people
divided by the risk that the same event happens in a second distinct group of people. In this …
divided by the risk that the same event happens in a second distinct group of people. In this …
Bildgebende Verfahren in der Diagnostik von Myopathien
NP Gossger - 2005 - opus.bibliothek.uni-wuerzburg.de
Ziel dieser Arbeit war es, die Aussagefähigkeit der Kernspintomographie mit der der
Histologie und der Sonographie im Hinblick auf Umbauvorgänge im Muskel in einem …
Histologie und der Sonographie im Hinblick auf Umbauvorgänge im Muskel in einem …
[CITATION][C] Pivotal Study Published In JAMA Confirms Potential Of Novartis Candidate Vaccine Bexsero To Help Protect Infants Against Devastating Meningococcal …
FI Human